Remove 2022 Remove Ethics Remove Safety
article thumbnail

Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines

European Pharmaceutical Review

How does that impact the safety of the biologics? Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. London: EMEA; 1997 [cited May 2022]. ICH, 1999 [cited May 2022].

Ethics 98
article thumbnail

New Bill could enhance UK clinical trial regulation

European Pharmaceutical Review

Benefits of The Future Clinical Trials Bill Chiefly, the Bill’s goal is to increase patient participation and overall, ensure clinical trials have the highest levels of safety while enabling greater regulatory pragmatism, the author explained. If achieved, this would boost the UK’s competitiveness as a leading international site for trials.

Ethics 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Janssen leads effort to cut waste in digital health devices

pharmaphorum

— Circular Digital Health (DiCE project) (@circular_health) October 13, 2022. The WEEE Forum notes that out of 16 ethical EU principles for digital health developed by the French Presidency of the EU, four focus on environmental sustainability, including eco-design, reuse, and recycling.

Leads 121
article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

In its 2022 edition, the Access to Medicine Foundation report 2 analyzed the access strategy of 180 products across the top 20 pharmaceutical companies, of which 102 are on the WHO essential medicine list. Access to Medicine Index 2022”: link In a shareholder meeting, Merck & Co. References: 1. Access to Medicine Foundation.

article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

The rule aims to regulate and enhance the transparency, effectiveness, and safety of predictive DSIs used in healthcare settings, ensuring that these technologies are developed and managed responsibly. The latest guidance was published just prior to the launch of ChatGPT in November 2022.

article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

The rule aims to regulate and enhance the transparency, effectiveness, and safety of predictive DSIs used in healthcare settings, ensuring that these technologies are developed and managed responsibly. The latest guidance was published just prior to the launch of ChatGPT in November 2022.

article thumbnail

Preparing for stricter standards on substances of human origin

European Pharmaceutical Review

On 14 July 2022, the European Commission published a proposal for a regulation on substances of human origin (SoHO) intended for human application. Covered SoHO activities are “action[s], or series of actions, that [have] a direct impact on safety, quality or efficacy of SoHOs.”

Safety 75